297 related articles for article (PubMed ID: 30626317)
41. Azole, polyene and echinocandin MIC distributions for wild-type, TR34/L98H and TR46/Y121F/T289A Aspergillus fumigatus isolates in the Netherlands.
van Ingen J; van der Lee HA; Rijs TA; Zoll J; Leenstra T; Melchers WJ; Verweij PE
J Antimicrob Chemother; 2015 Jan; 70(1):178-81. PubMed ID: 25301884
[TBL] [Abstract][Full Text] [Related]
42. cyp51A gene silencing using RNA interference in azole-resistant Aspergillus fumigatus.
Mousavi B; Hedayati MT; Teimoori-Toolabi L; Guillot J; Alizadeh A; Badali H
Mycoses; 2015 Dec; 58(12):699-706. PubMed ID: 26448519
[TBL] [Abstract][Full Text] [Related]
43. Multi-azole-resistant Aspergillus fumigatus in the environment in Tanzania.
Chowdhary A; Sharma C; van den Boom M; Yntema JB; Hagen F; Verweij PE; Meis JF
J Antimicrob Chemother; 2014 Nov; 69(11):2979-83. PubMed ID: 25006238
[TBL] [Abstract][Full Text] [Related]
44. Multiple cyp51A-based mechanisms identified in azole-resistant isolates of Aspergillus fumigatus from China.
Liu M; Zeng R; Zhang L; Li D; Lv G; Shen Y; Zheng H; Zhang Q; Zhao J; Zheng N; Liu W
Antimicrob Agents Chemother; 2015 Jul; 59(7):4321-5. PubMed ID: 25896700
[TBL] [Abstract][Full Text] [Related]
45. Epidemiology and Molecular Characterizations of Azole Resistance in Clinical and Environmental Aspergillus fumigatus Isolates from China.
Chen Y; Lu Z; Zhao J; Zou Z; Gong Y; Qu F; Bao Z; Qiu G; Song M; Zhang Q; Liu L; Hu M; Han X; Tian S; Zhao J; Chen F; Zhang C; Sun Y; Verweij PE; Huang L; Han L
Antimicrob Agents Chemother; 2016 Oct; 60(10):5878-84. PubMed ID: 27431231
[TBL] [Abstract][Full Text] [Related]
46. In vitro activity of the novel antifungal compound F901318 against difficult-to-treat Aspergillus isolates.
Buil JB; Rijs AJMM; Meis JF; Birch M; Law D; Melchers WJG; Verweij PE
J Antimicrob Chemother; 2017 Sep; 72(9):2548-2552. PubMed ID: 28605488
[TBL] [Abstract][Full Text] [Related]
47. High prevalence of triazole resistance in Aspergillus fumigatus, especially mediated by TR/L98H, in a French cohort of patients with cystic fibrosis.
Morio F; Aubin GG; Danner-Boucher I; Haloun A; Sacchetto E; Garcia-Hermoso D; Bretagne S; Miegeville M; Le Pape P
J Antimicrob Chemother; 2012 Aug; 67(8):1870-3. PubMed ID: 22581906
[TBL] [Abstract][Full Text] [Related]
48. Isolation of azole-resistant Aspergillus fumigatus from the environment in the south-eastern USA.
Hurst SF; Berkow EL; Stevenson KL; Litvintseva AP; Lockhart SR
J Antimicrob Chemother; 2017 Sep; 72(9):2443-2446. PubMed ID: 28575384
[TBL] [Abstract][Full Text] [Related]
49. Positive Aspergillus PCR as a marker of azole resistance or sub-therapeutic antifungal therapy in patients with chronic pulmonary aspergillosis.
Moazam S; Eades CP; Muldoon EG; Moore CB; Richardson MD; Rautemaa-Richardson R
Mycoses; 2020 Apr; 63(4):376-381. PubMed ID: 31981256
[TBL] [Abstract][Full Text] [Related]
50. Clinical implications of globally emerging azole resistance in Aspergillus fumigatus.
Meis JF; Chowdhary A; Rhodes JL; Fisher MC; Verweij PE
Philos Trans R Soc Lond B Biol Sci; 2016 Dec; 371(1709):. PubMed ID: 28080986
[TBL] [Abstract][Full Text] [Related]
51. Deletion of
Chen M; Zhong G; Wang S; Chen P; Li L
Antimicrob Agents Chemother; 2022 Jun; 66(6):e0015122. PubMed ID: 35647650
[TBL] [Abstract][Full Text] [Related]
52. Single-Center Evaluation of an Agar-Based Screening for Azole Resistance in Aspergillus fumigatus by Using VIPcheck.
Buil JB; van der Lee HAL; Rijs AJMM; Zoll J; Hovestadt JAMF; Melchers WJG; Verweij PE
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923874
[TBL] [Abstract][Full Text] [Related]
53. Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus.
van der Linden JW; Arendrup MC; Warris A; Lagrou K; Pelloux H; Hauser PM; Chryssanthou E; Mellado E; Kidd SE; Tortorano AM; Dannaoui E; Gaustad P; Baddley JW; Uekötter A; Lass-Flörl C; Klimko N; Moore CB; Denning DW; Pasqualotto AC; Kibbler C; Arikan-Akdagli S; Andes D; Meletiadis J; Naumiuk L; Nucci M; Melchers WJ; Verweij PE
Emerg Infect Dis; 2015 Jun; 21(6):1041-4. PubMed ID: 25988348
[TBL] [Abstract][Full Text] [Related]
54. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
Jensen RH
Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
[TBL] [Abstract][Full Text] [Related]
55. In Vitro Biochemical Study of CYP51-Mediated Azole Resistance in Aspergillus fumigatus.
Warrilow AG; Parker JE; Price CL; Nes WD; Kelly SL; Kelly DE
Antimicrob Agents Chemother; 2015 Dec; 59(12):7771-8. PubMed ID: 26459890
[TBL] [Abstract][Full Text] [Related]
56. Acquired antifungal drug resistance in Aspergillus fumigatus: epidemiology and detection.
Howard SJ; Arendrup MC
Med Mycol; 2011 Apr; 49 Suppl 1():S90-5. PubMed ID: 20795765
[TBL] [Abstract][Full Text] [Related]
57. In-host adaptation and acquired triazole resistance in Aspergillus fumigatus: a dilemma for clinical management.
Verweij PE; Zhang J; Debets AJM; Meis JF; van de Veerdonk FL; Schoustra SE; Zwaan BJ; Melchers WJG
Lancet Infect Dis; 2016 Nov; 16(11):e251-e260. PubMed ID: 27638360
[TBL] [Abstract][Full Text] [Related]
58. Long-chain unsaturated fatty acids are involved in the viability and itraconazole susceptibility of Aspergillus fumigatus.
Wang Y; Wang S; Zeng L; Han Z; Cao J; Wang Y; Zhong G
Biochem Biophys Res Commun; 2021 Dec; 585():82-88. PubMed ID: 34800884
[TBL] [Abstract][Full Text] [Related]
59. Azole-resistant Aspergillus fumigatus in Denmark: a laboratory-based study on resistance mechanisms and genotypes.
Jensen RH; Hagen F; Astvad KM; Tyron A; Meis JF; Arendrup MC
Clin Microbiol Infect; 2016 Jun; 22(6):570.e1-9. PubMed ID: 27091095
[TBL] [Abstract][Full Text] [Related]
60. Azole resistant Aspergillus fumigatus: an emerging problem.
Lelièvre L; Groh M; Angebault C; Maherault AC; Didier E; Bougnoux ME
Med Mal Infect; 2013 Apr; 43(4):139-45. PubMed ID: 23562488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
